Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RBLX vs GSK✓SelectedUSD · GSKRBLX vs GSK performance historyLatest closeAs of-4.60%11/17
Stock and ETF performance explorer

RBLX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+16.1%
GSK return
+58.9%
Excess return
-42.8%
Maximum drawdown
-74.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.6%-2.3%-2.3%-4.7%
7D-14.0%-3.0%-11.0%-14.1%
30D-11.2%+0.4%-11.6%-11.1%
3M+16.0%-1.2%+17.2%+15.9%
6M+2.7%+0.9%+1.8%+2.9%
YTD-45.7%+4.0%-49.7%-45.4%
1Y-56.6%+7.3%-63.8%-56.2%
3Y+16.1%+57.1%-41.0%+11.0%
All+16.1%+58.9%-42.8%+11.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling